From 2013 to 2023, the number of patents in the biotechnology sector in Belgium saw significant fluctuations. After recording various year-on-year growth rates and declines, the value stood at 181.48 units in 2023. Key trends include a consistent rise from 2017 onwards, despite a dip in 2020 due to a challenging environment, likely caused by the global pandemic. Notable growth spikes occurred in 2019 with a 46.78% increase. From 2019 onwards, the sector observed a somewhat steady incline, maintaining a 2.18% increase from 2022 to 2023.
Future forecasts indicate a continued rise in the number of biotechnology patents, with values projected to reach 200.57 units by 2028. The five-year CAGR from 2023 to 2028 is expected to average around 1.59%, suggesting moderate but steady growth.
Future trends to watch for in the biotechnology patent landscape include:
- Innovations driven by advancements in gene editing and personalized medicine
- Increased focus on sustainability and environmentally friendly biotech solutions
- Continued impact of global health crises driving research in vaccines and diagnostics